Challenges in modelling the Charcot-Marie-Tooth neuropathies for therapy development

Much has been achieved in terms of understanding the complex clinical and genetic heterogeneity of Charcot-Marie-Tooth neuropathy (CMT). Since the identification of mutations in the first CMT associated gene, PMP22, the technological advancement in molecular genetics and gene technology has allowed...

Descripción completa

Detalles Bibliográficos
Autores principales: Juneja, Manisha, Burns, Joshua, Saporta, Mario A, Timmerman, Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Neurogenetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327864/
https://www.ncbi.nlm.nih.gov/pubmed/30018047
http://dx.doi.org/10.1136/jnnp-2018-318834

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327864/
https://www.ncbi.nlm.nih.gov/pubmed/30018047
http://dx.doi.org/10.1136/jnnp-2018-318834

Ejemplares similares